Copyright
©The Author(s) 2018.
World J Gastroenterol. Feb 21, 2018; 24(7): 819-832
Published online Feb 21, 2018. doi: 10.3748/wjg.v24.i7.819
Published online Feb 21, 2018. doi: 10.3748/wjg.v24.i7.819
Figure 1 Effect of metformin in CCl4-induced fibrotic mice.
A fibrotic mouse model was induced by intraperitoneal injection of CCl4 (1 μL/g) dissolved in olive oil (CCl4:olive oil = 1:1, v/v) twice per week for 6 weeks. A and B: Histological changes were assessed by hematoxylin-eosin (H-E) staining and Sirius Red (S-R) staining (100 × magnification); C-E: Expression levels of α-SMA, fibronectin, and VEGF in the liver tissues were measured by immunohistochemistry (100 × magnification). Sirius Red staining was analyzed with ImageJ and immunohistochemical staining was analyzed with Image-Pro Plus 6.0. (Scale bar = 200 μm, n = 5, bP < 0.01 vs the control group, dP < 0.01 vs the CCl4 group).
- Citation: Li Z, Ding Q, Ling LP, Wu Y, Meng DX, Li X, Zhang CQ. Metformin attenuates motility, contraction, and fibrogenic response of hepatic stellate cells in vivo and in vitro by activating AMP-activated protein kinase. World J Gastroenterol 2018; 24(7): 819-832
- URL: https://www.wjgnet.com/1007-9327/full/v24/i7/819.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i7.819